High-Dose Cyclophosphamide in Highly Refractory Multiple Myeloma Patients As a Bridge to Further Novel Therapies

被引：3
|
作者：
Nikonova, Anna [1 ]
Caplan, Stephen N. [2 ]
Shamy, April [2 ]
Gyger, Martin [2 ]
机构：
[1] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
[2] McGill Univ, Jewish Gen Hosp, Montreal, PQ, Canada
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5676.5676
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5676
引用
收藏
页数：4
相关论文
共 50 条
  • [1] HIGH-DOSE CYCLOPHOSPHAMIDE - AN EFFECTIVE TREATMENT FOR REFRACTORY MULTIPLE-MYELOMA
    LENHARD, RE
    OKEN, MM
    HUMPHREY, RL
    BARNES, JM
    GLICK, JH
    BENNETT, JM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 537 - 537
  • [2] Rapid high-dose cyclophosphamide as bridging treatment for advanced therapies in multiple myeloma
    Marable, Marcus
    Kelly, Kaitlin
    Cooperrider, Jennifer H.
    Jakubowiak, Andrzej
    Derman, Benjamin A.
    EJHAEM, 2024, 5 (06): : 1260 - 1264
  • [3] HIGH-DOSE CYCLOPHOSPHAMIDE - AN EFFECTIVE TREATMENT FOR ADVANCED REFRACTORY MULTIPLE-MYELOMA
    LENHARD, RE
    OKEN, MM
    BARNES, JM
    HUMPHREY, RL
    GLICK, JH
    SILVERSTEIN, MN
    CANCER, 1984, 53 (07) : 1456 - 1460
  • [4] Immunoablation with high-dose cyclophosphamide for refractory multiple sclerosis
    Tilwalli, Shilpa
    Balabanov, Roumen
    Stefoski, Dusan
    Katsamakis, George
    Ko, Michael
    Shammo, Jamile
    Gregory, Stephanie
    MULTIPLE SCLEROSIS, 2008, 14 : S181 - S182
  • [5] High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis
    Gladstone, Douglas E.
    Zamkoff, Kenneth W.
    Krupp, Lauren
    Peyster, Robert
    Sibony, Patrick
    Christodoulou, Christopher
    Locher, Emily
    Coyle, Patricia K.
    ARCHIVES OF NEUROLOGY, 2006, 63 (10) : 1388 - 1393
  • [6] HIGH-DOSE DEXAMETHASONE FOR REFRACTORY OR RELAPSING MULTIPLE-MYELOMA
    FRIEDENBERG, WR
    KYLE, RA
    KNOSPE, WH
    BENNETT, JM
    TSIATIS, AA
    OKEN, MM
    AMERICAN JOURNAL OF HEMATOLOGY, 1991, 36 (03) : 171 - 175
  • [7] High-dose melphalan in patients with multiple myeloma
    Moreau, P
    Le Bonniec, M
    Harousseau, JL
    BULLETIN DU CANCER, 1999, 86 (03) : 283 - 288
  • [8] ETOPOSIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (EACB) AS OUTPATIENT SALVAGE THERAPY FOR REFRACTORY MULTIPLE-MYELOMA
    OHRLING, M
    BJORKHOLM, M
    OSTERBORG, A
    JULIUSSON, G
    BJOREMAN, M
    BRENNING, G
    CARLSON, K
    CELSING, F
    GAHRTON, G
    GRIMFORS, G
    GRUBER, A
    GYLLENHAMMAR, H
    HAST, R
    JOHANSSON, B
    JARNMARK, M
    KIMBY, E
    LERNER, R
    LINDER, O
    MERK, K
    PAUL, C
    SIMONSSON, B
    SMEDMYR, B
    SVEDMYR, E
    STALFELT, AM
    UDEN, AM
    OSBY, E
    MELLSTEDT, H
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1993, 51 (01) : 45 - 49
  • [9] High-dose chemotherapy with sequential double cycles of cyclophosphamide and melphalan in patients with multiple myeloma.
    Nowrousian, MR
    Wrzeciono, T
    Tewes, M
    Fossa, A
    Welt, A
    Schuett, P
    Brandhorst, D
    Kloke, O
    Schuette, J
    Seeber, S
    BLOOD, 2000, 96 (11) : 421A - 421A
  • [10] Infections in Patients with Multiple Myeloma in the Era of High-Dose Therapy and Novel Agents
    Nucci, Marcio
    Anaissie, Elias
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (08) : 1211 - 1225
12345